Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001304061 | SCV001493328 | uncertain significance | Usher syndrome type 3B | 2023-09-18 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with HARS-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HARS protein function. ClinVar contains an entry for this variant (Variation ID: 1006941). This variant is present in population databases (rs762921085, gnomAD 0.03%). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 217 of the HARS protein (p.Leu217Pro). |